Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Pivot

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 23, 2011
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II studyC Villanueva, A Awada, M Campone, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Primary lung sarcomas: long survivors obtained with iterative complete surgeryN Magné, B Porsin, X Pivot, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 25, 2012
Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugsV Nerich, C Borg, C Villanueva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patientsX Pivot, E Chamorey, E Guardiola, et al.
British Journal of Cancer|December 23, 1998
Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experienceA Llombart-Cussac, X Pivot, G Contesso, et al.
Breast (Edinburgh, Scotland)|November 30, 2011
Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapyN Chaumard, S Limat, C Villanueva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer studyX Pivot, J Gligorov, V Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patientsN Magné, X Pivot, M C Etienne-Grimaldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2011
Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysisA Thiery-Vuillemin, D Montange, E Kalbacher, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2017
Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer studyX Pivot, S Verma, L Fallowfield, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|February 23, 2011
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II studyC Villanueva, A Awada, M Campone, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Primary lung sarcomas: long survivors obtained with iterative complete surgeryN Magné, B Porsin, X Pivot, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 25, 2012
Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugsV Nerich, C Borg, C Villanueva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2003
Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patientsX Pivot, E Chamorey, E Guardiola, et al.
British Journal of Cancer|December 23, 1998
Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experienceA Llombart-Cussac, X Pivot, G Contesso, et al.
Breast (Edinburgh, Scotland)|November 30, 2011
Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapyN Chaumard, S Limat, C Villanueva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 30, 2014
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer studyX Pivot, J Gligorov, V Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Impact of platinum complexes on dihydropyrimidine dehydrogenase activity in 5-fluorouracil-treated patientsN Magné, X Pivot, M C Etienne-Grimaldi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2011
Impact of sunitinib pharmacokinetic monitoring in a patient with metastatic renal cell carcinoma undergoing hemodialysisA Thiery-Vuillemin, D Montange, E Kalbacher, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2017
Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer studyX Pivot, S Verma, L Fallowfield, et al.
Pageof 10